Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Zhenbin Xu; Hongpeng Duan; Yuling Shi; Zixia Zhou; Zhuo Wei; Xuechen Qian; Jian Lu; Yuemingming Jiang; Feng Mao; Nianyu Xue; Shengmin Zhang

doi:10.1039/D5RA90090E

View PDF VersionPrevious ArticleNext Article

Open Access Article

This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

DOI: 10.1039/D5RA90090E (Correction) RSC Adv., 2025, 15, 27923-27923

Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Zhenbin Xu^a, Hongpeng Duan^a, Yuling Shi^ab, Zixia Zhou^ab, Zhuo Wei^ab, Xuechen Qian^a, Jian Lu^a, Yuemingming Jiang^a, Feng Mao^a, Nianyu Xue^a and Shengmin Zhang*^ab
^aDepartment of Ultrasonography, The First Affiliated Hospital of Ningbo University, China. E-mail: fyyzhangshengmin@nbu.edu.cn
^bHealth Science Center, Ningbo University, Ningbo, China

Received 23rd July 2025 , Accepted 23rd July 2025

First published on 12th August 2025

Abstract

Correction for ‘Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer’ by Zhenbin Xu et al., RSC Adv., 2025, 15, 23136–23145, https://doi.org/10.1039/D5RA01016K.

The authors regret the omission of a funding acknowledgement in the original article. This acknowledgement is given here.

Acknowledgements

This research was critically supported by the following grants: Natural Science Foundation of Zhejiang Province (no. LBY23H180003) and Medical Science and Health Technology Project of Zhejiang Province (no. 2022KY319, 2022KY1065, and 2023KY1077).

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Click here to see how this site uses Cookies. View our privacy policy here.